Journal
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
Volume 195, Issue 5, Pages 1398-1403Publisher
MOSBY-ELSEVIER
DOI: 10.1016/j.ajog.2006.02.049
Keywords
preeclampsia; hypertension; heart; magnesium; rats
Categories
Funding
- NHLBI NIH HHS [1 R15 HL073777-01] Funding Source: Medline
Ask authors/readers for more resources
Objective: We hypothesized that cardiac function would be reduced in a pregnant rat model of preeclampsia induced by L-NAME, a NOS inhibitor, and be reversed with magnesium sulfate prophylaxis. Study design: Female Sprague-Dawley rats were bred in-house. On gestational day 17, rats were anesthetized and osmotic minipunips were implanted to continuously deliver saline, L-NAME, or L-NAME and MgSO4. On gestational day 21, hearts were isolated and perfused in the working mode using Krebs Henseleit buffer. Results: Pregnant rats treated with L-NAME displayed significant hypertension compared to the saline-treated controls (P < 0.05). Moreover, cardiac output and cardiac work were significantly reduced in the L-NAME-treated rats compared to controls (P < 0.05). In the L-NAME-treated rats given MgSO4, cardiac function remained normal. Conclusion: Cardiac function is depressed in an animal model of precclampsia induced by L-NAME infusion. MgSO4 prevented the reduction in cardiac function and is clearly beneficial in preserving normal heart function in preeclampsia. (c) 2006 Mosby, Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available